BioPharma Resources

Drugs by condition

Drugs approved for malaria

Brand-name prescription drugs and biologics whose FDA label lists malaria as an approved use. Matched on the label phrases: "malaria".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

9

Still marketed, NDA or BLA

Drug classes

2

Novel drugs

3

New molecular entities and new biologics

In development

7

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for malaria.

  • Sovuna (Hydroxychloroquine Sulfate) · Novitium Pharma Jan 14, 2022
  • Arakoda (Tafenoquine Succinate) · 60 Degrees Pharms Priority reviewAug 8, 2018
  • Krintafel (Tafenoquine Succinate) · Glaxosmithkline NovelBreakthrough therapyPriority reviewOrphanJul 20, 2018
  • Acticlate (Doxycycline Hyclate) · Chartwell Rx Jul 25, 2014
  • Coartem (Artemether, Lumefantrine) · Novartis NovelPriority reviewOrphanApr 7, 2009

All approved drugs for malaria, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 59 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Antimalarial (2)

  • Coartem Artemether, Lumefantrine · Novartis · 2009
  • Malarone Pediatric Atovaquone, Proguanil Hydrochloride · Glaxosmithkline · 2000

Class not listed in FDA's data (7)

  • Krintafel Tafenoquine Succinate · Glaxosmithkline · 2018
  • Plaquenil Hydroxychloroquine Sulfate · Advanz Pharma · 1955
  • Sovuna Hydroxychloroquine Sulfate · Novitium Pharma · 2022
  • Arakoda Tafenoquine Succinate · 60 Degrees Pharms · 2018
  • Acticlate Doxycycline Hyclate · Chartwell Rx · 2014
  • Doryx Mpc Doxycycline Hyclate · Mayne Pharma · 2005
  • Primaquine Primaquine Phosphate · Sanofi Aventis US · 1952

Drugs in development for malaria

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • KLU156Phase 34 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria

  • KAE609CipargaminPhase 25 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria, Severe Malaria

  • INE963Phase 23 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria

  • BNT165cPhase 21 trial

    BioNTech SE · Malaria

  • BNT165dPhase 21 trial

    BioNTech SE · Malaria

  • GSK3772701Phase 21 trial

    GSK · Malaria, Falciparum

  • M5717Phase 21 trial

    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection

1 discontinued brand-name drugs whose label still names it

More on malaria: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.